Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
J Intern Med ; 275(2): 127-33, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24010553

RESUMO

BACKGROUND: It is well established that subjects with moderately elevated plasma levels of C-reactive protein (CRP) have an increased risk of development of cardiovascular events. As atherosclerosis is a disease characterized by chronic arterial inflammation, it is possible that moderate increases in CRP level reflect the presence of plaque inflammation. To investigate this possibility, we compared plasma levels of hsCRP the day before carotid endarterectomy with the degree of inflammation in the excised plaque tissue. METHODS: Luminex immunoassays were used to determine the levels of IL-6, IL-10, monocyte chemoattractant protein-1 and tumour necrosis factor-α (TNF-α) in plasma and in homogenized plaque tissue from 160 endarterectomy specimens. Plaque sections were stained with antibodies against CD68 to determine the plaque macrophage content. RESULTS: Plasma high-sensitivity (hs)CRP levels were significantly correlated with plasma IL-6 and TNF-α. However, there were no significant associations between plasma hsCRP concentration and plaque cytokine levels or macrophage contents. CONCLUSIONS: The present findings strongly argue against hsCRP as a marker of plaque inflammation. Hence, it is more likely that elevated hsCRP is a sign of a subclinical systemic inflammation and this in turn may contribute to progression of cardiovascular disease.


Assuntos
Proteína C-Reativa/metabolismo , Estenose das Carótidas/sangue , Citocinas/sangue , Inflamação/sangue , Placa Aterosclerótica/sangue , Adulto , Idoso , Biomarcadores/sangue , Biomarcadores/metabolismo , Estenose das Carótidas/metabolismo , Estenose das Carótidas/patologia , Quimiocina CCL2/sangue , Citocinas/metabolismo , Feminino , Humanos , Imunoensaio , Interleucina-10/sangue , Interleucina-6/sangue , Masculino , Pessoa de Meia-Idade , Placa Aterosclerótica/metabolismo , Placa Aterosclerótica/patologia , Fatores de Risco , Fator de Necrose Tumoral alfa/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA